These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23931427)

  • 41. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
    Tozaki M; Naruo K; Fukuda K
    Radiat Med; 2005 Dec; 23(8):533-8. PubMed ID: 16555560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications.
    Hwang SH; Yu JS; Kim KW; Kim JH; Chung JJ
    J Comput Assist Tomogr; 2008; 32(1):39-45. PubMed ID: 18303286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
    Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma.
    Kawata S; Murakami T; Kim T; Hori M; Federle MP; Kumano S; Sugihara E; Makino S; Nakamura H; Kudo M
    AJR Am J Roentgenol; 2002 Jul; 179(1):61-6. PubMed ID: 12076906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.
    Sadigh G; Applegate KE; Baumgarten DA
    Acad Radiol; 2014 Jan; 21(1):113-25. PubMed ID: 24331274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective study comparing different iodine concentrations for triphasic multidetector row CT of the upper abdomen.
    Sandstede JJ; Werner A; Kaupert C; Roth A; Jenett M; Harz C; Hahn D
    Eur J Radiol; 2006 Oct; 60(1):95-9. PubMed ID: 16879942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.
    Baron RL; Oliver JH; Dodd GD; Nalesnik M; Holbert BL; Carr B
    Radiology; 1996 May; 199(2):505-11. PubMed ID: 8668803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of injection rate of contrast material on CT of hepatocellular carcinoma.
    Ichikawa T; Nakajima H; Nanbu A; Hori M; Araki T
    AJR Am J Roentgenol; 2006 May; 186(5):1413-8. PubMed ID: 16632738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
    Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
    AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
    Guerrisi A; Marin D; Nelson RC; De Filippis G; Di Martino M; Barnhart H; Masciangelo R; Guerrisi I; Passariello R; Catalano C
    Br J Radiol; 2011 Aug; 84(1004):698-708. PubMed ID: 21750137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.
    Zheng XH; Guan YS; Zhou XP; Huang J; Sun L; Li X; Liu Y
    World J Gastroenterol; 2005 Jan; 11(2):200-3. PubMed ID: 15633215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material.
    Ichikawa T; Erturk SM; Araki T
    Eur J Radiol; 2006 May; 58(2):165-76. PubMed ID: 16417983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individual Optimization of Contrast Media Injection Protocol at Hepatic Dynamic Computed Tomography Using Patient-Specific Contrast Enhancement Optimizer.
    Matsumoto Y; Higaki T; Arataki K; Masuda T; Sato T; Fukumoto W; Nakamura Y; Tatsugami F; Awai K
    J Comput Assist Tomogr; 2020; 44(2):230-235. PubMed ID: 32195801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aortic and Hepatic Contrast Enhancement During Hepatic-Arterial and Portal Venous Phase Computed Tomography Scanning: Multivariate Linear Regression Analysis Using Age, Sex, Total Body Weight, Height, and Cardiac Output.
    Masuda T; Nakaura T; Funama Y; Higaki T; Kiguchi M; Imada N; Sato T; Awai K
    J Comput Assist Tomogr; 2017; 41(2):309-314. PubMed ID: 27759599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.